These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


183 related items for PubMed ID: 7878951

  • 21. Induction of operational tolerance and generation of regulatory cells after intratracheal delivery of alloantigen combined with nondepleting anti-CD4 monoclonal antibody.
    Aramaki O, Shirasugi N, Akiyama Y, Takayama T, Shimazu M, Kitajima M, Ikeda Y, Niimi M.
    Transplantation; 2003 Nov 15; 76(9):1305-14. PubMed ID: 14627908
    [Abstract] [Full Text] [Related]

  • 22. Induction of specific unresponsiveness using transfected cells expressing donor major histocompatibility complex molecules: evidence for indirect presentation of allopeptides in vivo.
    Bell Y, Shoskes D, Morris P, Wood K.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 1):359. PubMed ID: 8438334
    [No Abstract] [Full Text] [Related]

  • 23. Spleen plays an important role in maintaining tolerance after removal of the vascularized heart graft.
    Chosa E, Hara M, Watanabe A, Matsuzaki Y, Nakamura K, Hamano K, Wood KJ, Onitsuka T.
    Transplantation; 2007 May 15; 83(9):1226-33. PubMed ID: 17496540
    [Abstract] [Full Text] [Related]

  • 24. Effect of anti-VCAM-1 and anti-VLA-4 monoclonal antibodies on cardiac allograft survival and response to soluble antigens in mice.
    Isobe M, Suzuki J, Yagita H, Okumura K, Sekiguchi M.
    Transplant Proc; 1994 Apr 15; 26(2):867-8. PubMed ID: 7513478
    [No Abstract] [Full Text] [Related]

  • 25. Tolerance induction by anti-CD2 plus anti-CD3 monoclonal antibodies: evidence for an IL-4 requirement.
    Punch JD, Tono T, Qin L, Bishop DK, Bromberg JS.
    J Immunol; 1998 Aug 01; 161(3):1156-62. PubMed ID: 9686574
    [Abstract] [Full Text] [Related]

  • 26. Microchimerism does not correlate with survival of murine cardiac allografts.
    de Moraes LV, Bueno V, Panajotopoulos N, Rizzo LV.
    Transplant Proc; 2004 May 01; 36(4):1021-2. PubMed ID: 15194355
    [Abstract] [Full Text] [Related]

  • 27. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N, Motoyama K, Yu S, Shimizu Y, Margenthaler J, Tu F, Flye MW.
    Surgery; 2000 Aug 01; 128(2):206-12. PubMed ID: 10922993
    [Abstract] [Full Text] [Related]

  • 28. Effect of anti-CD4 monoclonal antibody dosage when combined with donor antigen for the induction of transplantation tolerance.
    Pearson TC, Madsen JC, Wood KJ.
    Transplant Proc; 1991 Feb 01; 23(1 Pt 1):565-6. PubMed ID: 1990609
    [No Abstract] [Full Text] [Related]

  • 29. Microchimerism and heart allograft acceptance.
    Masaki Y, Hirasawa A, Okuyama S, Tsujimoto G, Iwaya M, Li XK, Yokoi Y, Nakamura S, Baba S, Miyamoto M.
    Transplant Proc; 1995 Feb 01; 27(1):148-50. PubMed ID: 7878949
    [No Abstract] [Full Text] [Related]

  • 30. Flt-3 ligand increases microchimerism but can prevent the therapeutic effect of donor bone marrow in transiently immunosuppressed cardiac allograft recipients.
    Antonysamy MA, Steptoe RJ, Khanna A, Rudert WA, Subbotin VM, Thomson AW.
    J Immunol; 1998 Apr 15; 160(8):4106-13. PubMed ID: 9558122
    [Abstract] [Full Text] [Related]

  • 31. Induction of transplantation tolerance by treatment with ICAM-1 antisense oligonucleotides and anti-LFA-1 monoclonal antibodies.
    Stepkowski SM, Tu Y, Condon TP, Bennett CF.
    Transplant Proc; 1995 Feb 15; 27(1):113. PubMed ID: 7878822
    [No Abstract] [Full Text] [Related]

  • 32. Prolonged survival of mouse cardiac allografts after CD4 or CD8 monoclonal antibody therapy is associated with selective intragraft cytokine protein expression: interleukin (IL)-4 and IL-10 but not IL-2 or interferon-gamma.
    Hancock W, Mottram PL, Purcell LJ, Han WR, Pietersz GA, McKenzie IF.
    Transplant Proc; 1993 Oct 15; 25(5):2937-8. PubMed ID: 8212290
    [No Abstract] [Full Text] [Related]

  • 33. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F, Chen Z, Xu S, Cai M, Wu M, Li H, Chen X.
    Surgery; 2009 Jun 15; 145(6):663-74. PubMed ID: 19486771
    [Abstract] [Full Text] [Related]

  • 34. Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice.
    Hamano K, Morris PJ, Wood KJ.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 1):792-3. PubMed ID: 8438483
    [No Abstract] [Full Text] [Related]

  • 35. Effects of exogenous IL-2 on tolerance induction by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
    Isobe M, Suzuki J, Yamazaki S, Sekiguchi M.
    Transplant Proc; 1996 Apr 15; 28(2):1045-6. PubMed ID: 8623222
    [No Abstract] [Full Text] [Related]

  • 36. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression.
    Wong W, Morris PJ, Wood KJ.
    Transplantation; 1997 May 27; 63(10):1490-4. PubMed ID: 9175815
    [Abstract] [Full Text] [Related]

  • 37. Immunosuppression by aminopterin or idarubicin conjugated to anti-CD8 in the mouse heart allograft model.
    Mottram PL, Pietersz GA, Purcell LJ, Krauer K, McKenzie IF.
    Transplant Proc; 1992 Oct 27; 24(5):2301. PubMed ID: 1413068
    [No Abstract] [Full Text] [Related]

  • 38. Successful secondary heterotopic cardiac transplantation in the mouse.
    Pearson TC, Darby CR, Wood KJ.
    Transplantation; 1992 Mar 27; 53(3):701-3. PubMed ID: 1549874
    [No Abstract] [Full Text] [Related]

  • 39. Patterns of allosensitization in allograft recipients: long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity.
    VanBuskirk AM, Wakely ME, Sirak JH, Orosz CG.
    Transplantation; 1998 Apr 27; 65(8):1115-23. PubMed ID: 9583874
    [Abstract] [Full Text] [Related]

  • 40. Effect of anti-CD4, anti-NC, and anti-NK monoclonal antibody on the survival of cardiac xenografts and allografts in mice.
    Yang L, Mottram PL, Han WR, Smart YC.
    Transplant Proc; 1995 Jun 27; 27(3):2185-6. PubMed ID: 7792927
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.